There are 2789 resources available
1065P - A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission
Presenter: Salvatore Alfieri
Session: ePoster Display
1066P - Extended-dose cemiplimab in patients with advanced cutaneous squamous cell carcinoma (CSCC): Primary analysis of phase II results
Presenter: Danny Rischin
Session: ePoster Display
1067P - Correlation between the number of risk factors and relapse in patients with cutaneous squamous cell carcinoma: A predictive factor for accurate adjuvant radiotherapy?
Presenter: Adeline Petre
Session: ePoster Display
1068P - Efficacy of combined hypo-fractionated radiotherapy (RT) in anti-PD-1 monotherapy-treated melanoma pts
Presenter: Philippe Saiag
Session: ePoster Display
1070P - Adjuvant treatment for melanoma in clinical practice: Trial versus reality
Presenter: Melissa De Meza
Session: ePoster Display
1071P - A nationwide, real-life study of outcome and quality of life after the introduction of adjuvant immunotherapy for Danish melanoma patients
Presenter: Eva Ellebaek
Session: ePoster Display
1072P - Primary ipilimumab/nivolumab immunotherapy followed by adjuvant nivolumab in patients with locally advanced or oligometastatic melanoma: Update on outcome
Presenter: Emilia Cocorocchio
Session: ePoster Display
1073P - Quality of life (QOL) endpoints from the phase III intergroup S1404 adjuvant melanoma trial
Presenter: Sapna Patel
Session: ePoster Display
1074P - Italian nivolumab Expanded Access Program (EAP) in melanoma adjuvant setting: Patients outcomes and safety profile
Presenter: Michele Del Vecchio
Session: ePoster Display